Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/03/2012CA2571782C Prostaglandin analogs
07/03/2012CA2568356C Bicyclic heterocycles as hiv integrase inhibitors
07/03/2012CA2567023C Compositions and methods for bone formation and remodeling
07/03/2012CA2564355C Protein kinase modulators and method of use
07/03/2012CA2561406C Heterocyclic compound and anti-malignant-tumor agent comprising the same as effective component
07/03/2012CA2538419C Use of ciclesonide for the treatment of respiratory diseases
07/03/2012CA2538405C Novel compounds
07/03/2012CA2536489C Compositions of isoquinolines and polymeric dialdehydes for veterinary and medical applications
07/03/2012CA2535953C Treating bone-related disorders with selective androgen receptor modulators
07/03/2012CA2529299C Indole derivatives as serotonin reuptake inhibitors
07/03/2012CA2526202C Compositions for treating infection in cattle and swine
07/03/2012CA2525547C Compounds and uses thereof in modulating amyloid beta
07/03/2012CA2522248C Methods of treatment using specific binding agents of human angiopoietin-2
07/03/2012CA2521648C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
07/03/2012CA2518934C Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
07/03/2012CA2518766C Anti-hepatitis c virus agents and anti-hiv agents
07/03/2012CA2517135C 1-n-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
07/03/2012CA2509899C Enantiomer (-) of tenatoprazole and the therapeutic use thereof
07/03/2012CA2509406C Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/03/2012CA2504153C Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
07/03/2012CA2493464C Microcapsules with modified release of active principles with low solubility for oral delivery
07/03/2012CA2492789C Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
07/03/2012CA2488785C Amine compound and use thereof
07/03/2012CA2485850C 8-azaprostaglandin analogs as agents for lowering intraocular pressure
07/03/2012CA2481192C Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
07/03/2012CA2475106C Use of cyclopentane heptanoic acid derivatives for enhancing hair growth
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2471041C Compositions and methods for enhancing corticosteriod delivery
07/03/2012CA2468958C Pulmonary delivery of aminoglycosides
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2445577C Subcellular targeting of therapeutic proteins
07/03/2012CA2441595C Proteins producing an altered immunogenic response and methods of making and using the same
07/03/2012CA2413164C Process for producing isomaltose and use thereof
07/03/2012CA2409647C Methods of treating androgen deficiency in men using selective antiestrogens
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2394086C 4-aminopiperidine derivatives and their use as medicine
07/03/2012CA2388818C C-aryl glucoside sglt2 inhibitors and method
07/03/2012CA2370805C Ureas as cell adhesion modulators
06/2012
06/30/2012CA2726599A1 Process for treprostinil salt preparation
06/28/2012WO2012088525A2 Methods for treating copd
06/28/2012WO2012088519A2 Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
06/28/2012WO2012088494A1 Novel morphinans useful as analgesics
06/28/2012WO2012088491A2 Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same
06/28/2012WO2012088469A1 Faah inhibitors
06/28/2012WO2012088433A1 Deuterated and/or fluorinated taxane derivatives
06/28/2012WO2012088431A1 Faah inhibitors
06/28/2012WO2012088425A2 Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
06/28/2012WO2012088411A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
06/28/2012WO2012088402A1 Synthesis of conolidine and discovery of a potent non-opioid analgesic for pain
06/28/2012WO2012088391A1 Non-ring hydroxy substituted taxanes and methods for synthesizing the same
06/28/2012WO2012088388A2 Treating multiple myeloma
06/28/2012WO2012088382A2 Amyris alcohol and its ester for treating acne
06/28/2012WO2012088379A2 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012WO2012088365A1 Bicyclo[3.2.1]octyl amide derivatives and uses of same
06/28/2012WO2012088314A1 Bicyclic pkm2 activators
06/28/2012WO2012088283A1 Small molecule compounds as broad-spectrum inhibitors of metallo-beta-lactamases
06/28/2012WO2012088268A2 Modulators for sirt6 and assays for screening same
06/28/2012WO2012088264A2 Purified cardiogenin isomer and related methods
06/28/2012WO2012088254A1 Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
06/28/2012WO2012088190A1 2,4,5-triaminothiophenols and related compounds
06/28/2012WO2012088178A1 Inhibitors of cytochrome p450 (cyp3a4)
06/28/2012WO2012088156A1 Inhibitors of cytochrome p450
06/28/2012WO2012088155A1 Cyclic nucleotide analogs
06/28/2012WO2012088153A1 Inhibitors of cytochrome p450
06/28/2012WO2012088124A2 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/28/2012WO2012088100A2 Triclabendazole and fenbendazole for cell protection
06/28/2012WO2012088044A2 Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity
06/28/2012WO2012088043A1 Enriched amaranthus blitoides compositions and uses
06/28/2012WO2012088038A2 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/28/2012WO2012088033A2 Novel pharmaceutical composition
06/28/2012WO2012088030A1 Combination
06/28/2012WO2012088015A2 Substituted hydroxamic acids and uses thereof
06/28/2012WO2012088001A2 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus
06/28/2012WO2012087976A2 Novel inhibitors of hepatitis c virus replication
06/28/2012WO2012087938A1 Quinazolinone derivatives as antiviral agents
06/28/2012WO2012087927A1 Novel preparation of an enteric release system
06/28/2012WO2012087889A2 Dna methylation inhibitors
06/28/2012WO2012087881A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/28/2012WO2012087872A1 Quinolines and aza-quinolines as crth2 receptor modulators
06/28/2012WO2012087861A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
06/28/2012WO2012087833A1 Hepatitis c inhibitors and uses thereof
06/28/2012WO2012087782A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
06/28/2012WO2012087777A1 Fused heterocyclic indane carboxamide cgrp receptor antagonists
06/28/2012WO2012087772A1 Indazole derivatives useful as erk inhibitors
06/28/2012WO2012087771A1 Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
06/28/2012WO2012087745A1 Methods and compositions for preventing and treating osteoarthritis
06/28/2012WO2012087742A2 Methods and compositions suitable for managing blood glucose in animals
06/28/2012WO2012087630A1 Pyridine and pyrimidine compounds for controlling invertebrate
06/28/2012WO2012087596A1 Combinations for treating hcv
06/28/2012WO2012087521A1 Compositions and methods for modulating farnesoid x receptors
06/28/2012WO2012087520A1 Compositions and methods for modulating farnesoid x receptors
06/28/2012WO2012087519A1 Compositions and methods for modulating fxr
06/28/2012WO2012087453A1 Long wearing powder-based cosmetic compositions
06/28/2012WO2012087443A1 Pharmaceutical formulations containing corticosteroids for topical administration
06/28/2012WO2012087389A1 Novel 19-nor-steroids and their use for treating progesterone-dependent conditions
06/28/2012WO2012087377A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012WO2012087289A1 Halogenated biphenols as antibacterial agents
06/28/2012WO2012087237A1 Compounds and their use as bace inhibitors
06/28/2012WO2012087236A1 Compounds and their use as bace inhibitors
1 ... 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 ... 7860